No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

The multicenter international Society for Immunotherapy of Cancer (SITC) study of the consensus Immunoscore demonstrated the prediction of survival and response to chemotherapy in 763 Stage III colon cancer (CC) patients. Similar Immunoscore groups were found in elderly patients, and densities of im...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascierto, Paolo A., Marincola, Francesco M., Fox, Bernard A., Galon, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Author’s View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644246/
https://www.ncbi.nlm.nih.gov/pubmed/33194317
http://dx.doi.org/10.1080/2162402X.2020.1826132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644246/
https://www.ncbi.nlm.nih.gov/pubmed/33194317
http://dx.doi.org/10.1080/2162402X.2020.1826132

Ejemplares similares